Key result
Multi-trait association studies identified three previously unreported pleiotropic associations at known Alzheimer's disease loci and four novel pleiotropic loci shared with cardiometabolic traits.
Why the study?
Previous epidemiological correlations observed between cardiometabolic traits and Alzheimer's disease led to assessing pleiotropy to improve understanding of disease etiology and detect therapeutic targets.
Observational
Shared genetic loci between Alzheimer's disease and cardiometabolic traits suggest that blood pressure and immune response pathways, including the ACE gene, play a role in their pleiotropy.
Answers are grounded in this paper and cite their sources.
Extends evidence for shared Alzheimer's-cardiometabolic genetics; hypothesis-generating and should not yet change practice.
BACKGROUND: Identification of genetic risk factors that are shared between Alzheimer's disease (AD) and other traits, i.e., pleiotropy, can help improve our understanding of the etiology of AD and potentially detect new therapeutic targets. Previous epidemiological correlations observed between cardiometabolic traits and AD led us to assess the pleiotropy between these traits. METHODS: We performed a set of bivariate genome-wide association studies coupled with colocalization analysis to identify loci that are shared between AD and eleven cardiometabolic traits. For each of these loci, we performed colocalization with Genotype-Tissue Expression (GTEx) project expression quantitative trait loci (eQTL) to identify candidate causal genes. RESULTS: We identified three previously unreported pleiotropic trait associations at known AD loci as well as four novel pleiotropic loci. One associated locus was tagged by a low-frequency coding variant in the gene DOCK4 and is potentially implicated in its alternative splicing. Colocalization with GTEx eQTL data identified additional candidate genes for the loci we detected, including ACE, the target of the hypertensive drug class of ACE inhibitors. We found that the allele associated with decreased ACE expression in brain tissue was also associated with increased risk of AD, providing human genetic evidence of a potential increase in AD risk from use of an established anti-hypertensive therapeutic. CONCLUSION: Our results support a complex genetic relationship between AD and these cardiometabolic traits, and the candidate causal genes identified suggest that blood pressure and immune response play a role in the pleiotropy between these traits.
No takes yet. Share an insight, caveat, or question.
Bone et al. (2021) conducted an observational in Alzheimer's disease and cardiometabolic traits. Genetic pleiotropy (shared loci) was evaluated on Pleiotropic loci between Alzheimer's disease and cardiometabolic traits. Multi-trait association studies identified three previously unreported pleiotropic associations at known Alzheimer's disease loci and four novel pleiotropic loci shared with cardiometabolic traits.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: